Q3 2024 |
68 |
$6.91B |
+$542M |
-$396M |
+$146M |
MDGL, AXSM, RNA, ARGX, NTRA
|
13F-HR |
11/14/2024, 09:09 AM |
Q2 2024 |
68 |
$6.46B |
+$1.01B |
-$751M |
+$257M |
MDGL, RCKT, AXSM, RNA, ARGX
|
13F-HR |
8/14/2024, 08:50 AM |
Q1 2024 |
69 |
$6.77B |
+$1.12B |
-$1.21B |
-$97M |
RCKT, IMCR, AXSM, RARE, BRKR
|
13F-HR |
5/15/2024, 07:43 AM |
Q4 2023 |
64 |
$6.4B |
+$1B |
-$361M |
+$641M |
RCKT, IMCR, MRTX, AXSM, ACAD
|
13F-HR |
2/14/2024, 06:05 AM |
Q3 2023 |
67 |
$4.74B |
+$561M |
-$262M |
+$299M |
RCKT, IMCR, AXSM, ALNY, MRTX
|
13F-HR |
11/14/2023, 06:09 AM |
Q2 2023 |
62 |
$5.25B |
+$738M |
-$425M |
+$313M |
IMCR, RCKT, ALNY, AXSM, PTCT
|
13F-HR |
8/14/2023, 07:21 AM |
Q1 2023 |
60 |
$4.8B |
+$542M |
-$481M |
+$60.8M |
RXDX, PTCT, ALNY, RCKT, IMCR
|
13F-HR |
5/15/2023, 06:26 AM |
Q4 2022 |
77 |
$4.9B |
+$444M |
-$145M |
+$300M |
ALNY, RXDX, RCKT, IMCR, TMO
|
13F-HR |
2/14/2023, 08:09 AM |
Q3 2022 |
86 |
$4.34B |
+$241M |
-$319M |
-$78.5M |
ALNY, PTCT, RCKT, TMO, IMCR
|
13F-HR |
11/14/2022, 05:10 PM |
Q2 2022 |
107 |
$3.87B |
+$486M |
-$182M |
+$304M |
ALNY, TMO, RCKT, PTCT, MASI
|
13F-HR |
8/15/2022, 01:00 PM |
Q1 2022 |
106 |
$4.83B |
+$330M |
-$1.23B |
-$900M |
ALNY, RCKT, TMO, PTCT, ILMN
|
13F-HR |
5/16/2022, 11:15 AM |
Q4 2021 |
124 |
$6.85B |
+$946M |
-$301M |
+$645M |
SPY, RCKT, ALNY, TMO, MASI
|
13F-HR |
2/14/2022, 09:27 AM |
Q3 2021 |
120 |
$6.63B |
+$792M |
-$310M |
+$483M |
RCKT, SPY, ALNY, MRTX, TMO
|
13F-HR |
11/15/2021, 04:46 PM |
Q2 2021 |
113 |
$6.63B |
+$522M |
-$602M |
-$80M |
RCKT, SPY, ALNY, DRNA, VCEL
|
13F-HR |
8/13/2021, 04:31 PM |
Q1 2021 |
111 |
$6.41B |
+$1.18B |
-$315M |
+$866M |
RCKT, SPY, VCEL, PTCT, ALNY
|
13F-HR |
5/14/2021, 01:01 PM |
Q4 2020 |
102 |
$5.96B |
+$971M |
-$463M |
+$508M |
RCKT, IMVT, PTCT, MRTX, STOK
|
13F-HR |
2/16/2021, 02:40 PM |
Q3 2020 |
90 |
$4.15B |
+$628M |
-$107M |
+$521M |
RCKT, IMVT, ALNY, PTCT, MRTX
|
13F-HR |
11/16/2020, 03:20 PM |
Q2 2020 |
77 |
$3.55B |
+$767M |
-$305M |
+$461M |
RCKT, ALNY, PTCT, DRNA, ADVM
|
13F-HR |
8/14/2020, 03:18 PM |
Q1 2020 |
65 |
$2.32B |
+$370M |
-$89M |
+$281M |
RCKT, ALNY, PTCT, DRNA, BMY
|
13F-HR |
5/15/2020, 04:19 PM |
Q4 2019 |
1 |
$20.5M |
$0 |
$0 |
|
MDXG
|
New Holdings |
2/14/2020, 04:45 PM |
Q4 2019 |
61 |
$2.65B |
+$372M |
-$163M |
+$209M |
RCKT, ALNY, PTCT, DRNA, AXSM
|
13F-HR |
2/14/2020, 12:34 PM |
Q3 2019 |
60 |
$1.68B |
+$270M |
-$132M |
+$138M |
RCKT, ALNY, PTCT, DRNA, BMY
|
13F-HR |
11/14/2019, 03:37 PM |
Q2 2019 |
52 |
$1.87B |
+$515M |
-$148M |
+$367M |
RCKT, ALNY, PTCT, DRNA, STOK
|
13F-HR |
8/14/2019, 08:59 AM |
Q1 2019 |
50 |
$1.47B |
+$345M |
-$191M |
+$154M |
RCKT, PTCT, DRNA, ALNY, BMY
|
13F-HR |
5/15/2019, 10:16 AM |
Q4 2018 |
1 |
$15.5M |
$0 |
$0 |
|
BVX
|
New Holdings |
2/15/2019, 04:31 PM |
Q4 2018 |
47 |
$1.09B |
+$217M |
-$325M |
-$108M |
RCKT, ARWR, PTCT, DRNA, BMY
|
Restatement |
2/15/2019, 04:24 PM |
Q3 2018 |
46 |
$1.67B |
+$238M |
-$267M |
-$28.6M |
RCKT, PTCT, ARWR, RGNX, DRNA
|
13F-HR |
11/14/2018, 10:25 AM |
Q2 2018 |
40 |
$1.39B |
+$244M |
-$106M |
+$138M |
RCKT, RGNX, PTCT, SRPT, ARWR
|
13F-HR |
8/14/2018, 09:35 AM |
Q1 2018 |
38 |
$1.05B |
+$466M |
-$85M |
+$381M |
RCKT, PTCT, BMY, RGNX, SRPT
|
13F-HR |
5/14/2018, 09:23 AM |
Q4 2017 |
32 |
$599M |
+$138M |
-$88.4M |
+$49.8M |
PTCT, RGNX, BMY, ALNY, DRNA
|
Restatement |
2/28/2018, 05:21 PM |
Q3 2017 |
27 |
$574M |
+$68.8M |
-$84.5M |
-$15.7M |
ALNY, PTCT, BMY, RGNX, AVXS
|
13F-HR |
11/14/2017, 06:05 AM |
Q2 2017 |
28 |
$474M |
+$103M |
-$52.3M |
+$50.9M |
ALNY, PTCT, AVXS, BMY, LJPC
|
13F-HR |
8/14/2017, 03:38 PM |
Q1 2017 |
28 |
$380M |
+$80.4M |
-$39.2M |
+$41.1M |
ALNY, AVXS, BMY, LJPC, BCRX
|
13F-HR |
5/15/2017, 02:56 PM |
Q4 2016 |
31 |
$265M |
+$61.3M |
-$65.4M |
-$4.13M |
AVXS, BMY, ALNY, BCRX, LJPC
|
13F-HR |
2/14/2017, 06:39 PM |
Q3 2016 |
34 |
$330M |
+$75.6M |
-$100M |
-$24.8M |
ALNY, AVXS, AGEN, LJPC, BCRX
|
Restatement |
11/18/2016, 11:49 AM |
Q2 2016 |
34 |
$292M |
+$53.3M |
-$23.8M |
+$29.6M |
ALNY, INCY, BLUE, ACHN, LJPC
|
13F-HR |
8/15/2016, 09:38 AM |
Q1 2016 |
32 |
$275M |
+$84.3M |
-$25.5M |
+$58.7M |
ALNY, INCY, LJPC, ACHN, KITE
|
13F-HR |
5/11/2016, 04:46 PM |
Q4 2015 |
9 |
$4.63M |
$0 |
$0 |
|
MASI, ANIK, MDRX, GHDX, NTRA
|
New Holdings |
5/24/2016, 01:41 PM |
Q4 2015 |
35 |
$307M |
+$42.1M |
-$96.5M |
-$54.4M |
ALNY, LJPC, OMER, KITE, DRNA
|
Restatement |
5/24/2016, 01:39 PM |
Q3 2015 |
40 |
$319M |
+$109M |
-$30.4M |
+$78.7M |
ALNY, INCY, LJPC, BCRX, KITE
|
Restatement |
5/24/2016, 01:38 PM |
Q2 2015 |
32 |
$318M |
+$119M |
-$59M |
+$60.2M |
ALNY, BCRX, KITE, ACHN, INCY
|
13F-HR |
8/14/2015, 10:06 AM |
Q1 2015 |
24 |
$222M |
+$39.9M |
-$95.1M |
-$55.2M |
ALNY, DYAX, DRNA, KITE, BCRX
|
13F-HR |
5/21/2015, 04:10 PM |
Q4 2014 |
21 |
$270M |
$0 |
$0 |
|
TARO, ALNY, DYAX, BCRX, ACHN
|
13F-HR |
2/17/2015, 10:07 AM |